Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma
NCT01083966
·
clinicaltrials.gov ↗
PHASE1
Phase
SUSPENDED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Vestibular Schwannoma
Interventions
DRUG:
Bevacizumab (Avastin)
Sponsor
Northwell Health
Collaborators
[object Object]
[object Object]